Ancora Heart

Ancora Heart is a medical device company based in Santa Clara, CA, dedicated to helping people with heart failure feel better and live longer. The company developed the AccuCinch Ventricular Restoration System, described as the only completely transcatheter device designed to treat the enlarged left ventricle, restore structure and function, and bring relief to heart failure patients who remain symptomatic despite current guideline-directed medical care. The AccuCinch Ventricular Restoration System has been granted Breakthrough Device Designation by the FDA and is an investigational device limited by United States law to investigational use. Ancora Heart states it is currently enrolling patients in a randomized, controlled clinical trial called The CORCINCH-HF Study.

Ancora Heart is a medical device company based in Santa Clara, CA, dedicated to helping people with heart failure feel better and live longer. The company states that its team has a deep appreciation for the challenges faced by the estimated 26 million patients across the globe living with heart failure. To address this challenge, Ancora Heart developed the AccuCinch Ventricular Restoration System, described as the only completely transcatheter device designed to treat the enlarged left ventricle, restore structure and function, and bring relief to heart failure patients who remain symptomatic despite current guideline-directed medical care. The AccuCinch Ventricular Restoration System has been granted Breakthrough Device Designation by the FDA and is an investigational device limited by United States law to investigational use. Ancora Heart states that early feasibility clinical data has demonstrated the potential of the AccuCinch System to improve quality of life, improve functional capacity, and initiate a process of reverse remodeling in patients who have heart failure with reduced ejection fraction (HFrEF), and that it is currently enrolling patients in a randomized, controlled clinical trial called The CORCINCH-HF Study.

Developer of the AccuCinch Ventricular Restoration System, described as the only completely transcatheter device designed to treat the enlarged left ventricle.

• AccuCinch Ventricular Restoration System

  An innovative therapy that opens up treatment possibilities for patients with heart failure, also known as congestive heart failure or CHF. Described as the only completely transcatheter device designed to treat the enlarged left ventricle, restore structure and function and bring relief to heart failure patients who remain symptomatic despite current guideline-directed medical care. Granted Breakthrough Device Designation by the FDA; investigational device limited by United States law to investigational use.

1. 1Heart Failure Treatment Options and Clinical Trials | Ancora Heartancoraheart.com
2. 2About Us | Medical Device Company California | Ancora Heartancoraheart.com